4.04
前日終値:
$3.85
開ける:
$3.9
24時間の取引高:
279.20K
Relative Volume:
0.85
時価総額:
$218.18M
収益:
$77.36M
当期純損益:
$-38.43M
株価収益率:
-5.4536
EPS:
-0.7408
ネットキャッシュフロー:
$-29.92M
1週間 パフォーマンス:
+9.49%
1か月 パフォーマンス:
-22.01%
6か月 パフォーマンス:
+17.78%
1年 パフォーマンス:
+50.19%
Sight Sciences Inc Stock (SGHT) Company Profile
Compare SGHT vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
SGHT
Sight Sciences Inc
|
4.04 | 207.92M | 77.36M | -38.43M | -29.92M | -0.7408 |
|
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-05 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-08-08 | アップグレード | Lake Street | Hold → Buy |
| 2024-12-06 | 開始されました | UBS | Buy |
| 2024-11-04 | ダウングレード | Lake Street | Buy → Hold |
| 2024-08-21 | 開始されました | Lake Street | Buy |
| 2023-09-12 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-09-12 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-01-06 | アップグレード | Stifel | Hold → Buy |
| 2022-10-04 | 開始されました | Needham | Hold |
| 2022-07-26 | 開始されました | Stifel | Hold |
| 2022-02-03 | 開始されました | William Blair | Outperform |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
すべてを表示
Sight Sciences Inc (SGHT) 最新ニュース
Aug Ideas: Is Sight Sciences Inc in a consolidation phase2026 Highlights & High Accuracy Investment Signals - baoquankhu1.vn
Sight Sciences Inc stock faces pressure amid weak Q4 guidance and slowing growth in eye care devices - AD HOC NEWS
Citigroup maintains Sight Sciences (SGHT) neutral recommendation - MSN
Sight Sciences outlines $82M–$88M 2026 revenue target while expanding interventional dry eye strategy - MSN
Can Sight Sciences Inc weather a recession2026 Technical Overview & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Earnings call transcript: Sight Sciences beats Q4 2025 forecasts, stock rises - Investing.com Nigeria
Prosight Management LP Sells 431,746 Shares of Sight Sciences, Inc. $SGHT - MarketBeat
Morgan Stanley Sticks to Its Hold Rating for Sight Sciences (SGHT) - The Globe and Mail
Sight Sciences (SGHT) Q4 2025 Earnings Transcript - AOL.com
Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2025 earnings call transcript - MSN
Sight Sciences Earnings Call Highlights Disciplined Growth - TipRanks
Stock Report: Can Sight Sciences Inc weather a recession2025 Volume Leaders & Low Volatility Stock Suggestions - baoquankhu1.vn
Sight Sciences, Inc. (SGHT) reports Q4 loss, beats revenue estimates - MSN
S P Trends: Will Sight Sciences Inc outperform tech stocks2025 Bull vs Bear & Long-Term Safe Investment Ideas - baoquankhu1.vn
Sight Sciences Shareholders Are Encouraged to Reach Out to - GlobeNewswire
Sight Sciences (NASDAQ:SGHT) Price Target Cut to $11.00 by Analysts at UBS Group - MarketBeat
Sight Sciences (NASDAQ:SGHT) Price Target Lowered to $6.50 at Citigroup - MarketBeat
Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2025 Earnings Call Transcript - Insider Monkey
Sight Sciences (SGHT) reports Q4 earnings: What key metrics have to say - MSN
William Blair Maintains Outperform on SGHT Sight Sciences, Inc. March 2026 - Meyka
Sight Sciences Reports Preliminary Fourth Quarter 2025 Revenue Growth, Provides 2026 Outlook - VisionMonday.com
Sight Sciences (SGHT) EPS Loss Narrows Again And Tests Bearish Profitability Narratives - simplywall.st
William Blair reiterates Sight Sciences stock rating on expense control - Investing.com Nigeria
William Blair reiterates Sight Sciences stock rating on expense control By Investing.com - Investing.com India
Sight Sciences, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Sight Sciences Q4 Net Loss Narrows; Expects 6-14% Revenue Growth In FY26 - Nasdaq
Sight Sciences sees FY26 revenue $82M-$88M, consensus $86.11M - TipRanks
Sight Sciences Q4 2025 Earnings Call Transcript - MarketBeat
Earnings call transcript: Sight Sciences beats Q4 2025 forecasts, stock rises By Investing.com - Investing.com South Africa
Sight Sciences Q4 Earnings Call Highlights - MarketBeat
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates - Bitget
Sight Sciences (SGHT) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance
Sight Sciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Sight Sciences reports Q4 EPS (8c), consensus (14c) - TipRanks
Sight Sciences Q4 Loss Narrows, Revenue Rises - marketscreener.com
Sight Sciences earnings beat by $0.07, revenue topped estimates - Investing.com Canada
Sight Sciences Inc. (SGHT) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Sight Sciences (NASDAQ:SGHT) Posts Quarterly Earnings Results - MarketBeat
Sight Sciences Q4 Earnings Assessment - Benzinga
Sight Sciences Posts Q4 Growth, Issues 2026 Outlook - TipRanks
SGHT: OMNI and TearCare drive innovation in eyecare, targeting large, underserved markets - TradingView
Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance - The Manila Times
Sight Sciences (SGHT) outlines interventional glaucoma and dry eye growth plan - Stock Titan
Sight Sciences, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and 2026 Guidance - Quiver Quantitative
Sight Sciences (NASDAQ: SGHT) narrows 2025 loss and targets 6–14% growth - Stock Titan
Eye-care firm Sight Sciences targets up to 14% 2026 growth after $38M 2025 loss - Stock Titan
SGHT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sight Sciences Inc (SGHT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Uncovering Potential: Sight Sciences's Earnings Preview - Benzinga
5 Analysts Assess Sight Sciences: What You Need To Know - Benzinga
Stifel raises Sight Sciences stock price target on TearCare survey By Investing.com - Investing.com Canada
Sight Sciences Inc (SGHT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):